Shukra Pharmaceuticals Rights Issue 2023 Latest News Today

1. 2023 SAG-AFTRA Agreements

   July 1, 2024 6:39:00 AM

   A breakdown of the new collective bargaining agreements between the Screen Actors Guild-American Federation of Television and Radio Artists (SAG-AFTRA) and the Alliance of Motion Picture and ...

   Published by : Reuters

2. Future Pak withdraws offer to buy Vanda Pharmaceuticals

   June 27, 2024 10:27:00 PM

   as well as another offer from UK-based Cycle Pharmaceutical, adding that both offers undervalued it. Vanda, which rejected a buyout offer from Future Pak for the third time, adopted a shareholder ...

   Published by : Reuters

3. Emcure Pharmaceuticals IPO: Latest GMP of Pharma queen Namita Thapar-linked public issue

   July 1, 2024 12:35:55 PM

   Shares of the Shark Tank fame Namita Thapar-linked Emcure Pharmaceuticals have shot up sharply ahead of the opening date of its IPO on July 3. Check latest grey market premium of Emcure ...

   Published by : ET Now on MSN

4. Emcure Pharma gets SEBI nod for public issue

   June 21, 2024 7:38:22 AM

   MUMBAI: Pune-based drug maker Emcure Pharmaceuticals has received the regulatory approvals to launch a Rs 2,500 crore initial share sale, which is just half of what it originally planned in early 2023 ...

   Published by : The New Indian Express on MSN

Read Shukra Pharmaceuticals Rights Issue 2023 current news. Find Shukra Pharmaceuticals Rights Issue 2023 subscription news, Rights Issue analysis, broker reviews, allotment news, and listing date. Get the Shukra Pharmaceuticals Limited Rights Issue grey market premium and Shukra Pharmaceuticals Rights Issue 2023 expected listing price.

Read more about Shukra Pharmaceuticals Rights Issue 2023

• Shukra Pharmaceuticals Rights Issue 2023 Detail
• Shukra Pharmaceuticals Rights Issue 2023 Review
• Shukra Pharmaceuticals Rights Issue 2023 FAQ's
• Shukra Pharmaceuticals Rights Issue 2023 Live News
• Shukra Pharmaceuticals Rights Issue 2023 Rights Issue Calendar Events